Skip to content

Efficacy of Animal-assisted Therapy in Patients With Borderline Personality Disorder and Addictions.

Efficacy of Animal-assisted Therapy in Patients With Borderline Personality Disorder and Addictions.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05115266
Enrollment
200
Registered
2021-11-10
Start date
2022-04-30
Completion date
2025-04-30
Last updated
2021-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnosis, Dual (Psychiatry)

Keywords

Animal-assisted therapy, Borderline personality disorder, substance abuse, Dual pathology, Residential treatment

Brief summary

Animal-assisted therapy (AAT) is a complementary intervention of therapy that has shown positive results in the treatment of various pathologies. This study assesses the viability of the implementation and the effectiveness of an AAT program in patients diagnosed with borderline personality disorder and substance abuse disorder. Our hypotheses are that participation in the TAA program will reduce negative symptoms, improve the quality of life of people with dual pathology, whose mental illness is schizophrenia, and increase adherence to treatment for people with dual pathology, whose mental disorder it's schizophrenia.

Detailed description

Animal assisted therapy (AAT) is a complementary intervention to therapy that presents positive results in the treatment of different pathologies. The study assesses the implementation and effectiveness of a TAA program in patients diagnosed with borderline personality disorder and substance abuse disorder.

Interventions

BEHAVIORALAnimal-assisted therapy (AAT

The activity program consists of 10 sessions with a duration of about 60 minutes. During the 10 sessions the animal is presented, in this case a dog. They caress it, dress it, educate it ...

BEHAVIORALUsual treatment

receive usual treatment (group activities)

Sponsors

Miguel Monfort Montolio
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Meeting DSM-5 criteria for substance abuse disorder and the presence of borderline personality disorder. * Voluntary participant in the study and having signed the informed consent

Exclusion criteria

* Patients whose functioning could be altered by factors not specifically related to addictive pathology or mental disorder (severe cognitive impairment, intellectual deficiency or language barrier) * Animal-specific phobia

Design outcomes

Primary

MeasureTime frameDescription
The Life Skills Profile questionnaire (LSP)Change from Life Skills at 3-6-9 months (12 minutes)This questionnaire evaluates aspects of functioning that affect daily activities and the adaptation of people with mental illnesses in the community. It contains 39 items that are grouped into self-care, social-interpersonal behaviour, communication-social contact, non-personal social behavior and autonomous life
Barrat impulsiveness scale (BIS-11)Change from impulsiveness at 3-6-9 months (12 minutes)This instrument is composed of 30 items distributed into three sub-scales: nonplanning, motor and attentional. The total impulsiveness score was also obtained
Calgary Depresión Scale for Schizophrenia (CDSS)Change from Depresión at 3-6-9 months (12 minutes)The questionnaire is a structured instrument, administered by a clinician in a hetero-applied way for the adult population, with an approximate administration time of between 10 and 30 minutes, and covers the therapeutic area related to the symptoms of depressive disorders.
Rosenberg Self-Esteem ScaleChange from self-esteem at 3-6-9 months (12 minutes)The questionnaire consists of 10 statements of the feelings that the person has about himself. Five of the statements are addressed positively (items 1, 2, 4, 6 and 7) and 5 negatively (items 3, 5, 8, 9 and 10).
Positive and negative symptom scale (PANSS)Change from Positive and negative symptom at 3-6-9 months (12 minutes)It is a semi-structured and hetero-applied questionnaire for the adult population. The application time is between 30-60 minutes and evaluates the positive and negative symptoms of schizophrenia and other psychotic disorders

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026